By Bob Herman
Sept. 20, 2024
Business of Health Care Reporter
Amazon is terminating its contract with Progyny, a company that sells fertility benefits such as in vitro fertilization and egg freezing to employers, according to a source familiar with the matter.
Starting Jan. 1, 2025, Amazon employees will no longer have access to Progyny’s services. Instead, Amazon will use Maven as its fertility benefits vendor, the person said. Amazon already had a relationship with Maven for virtual “family-building care.” The person asked not to be identified because Amazon is still communicating the change to its workers.
advertisement
On Wednesday, Progyny disclosed to investors that a “significant client” had decided to end its agreement with the company. Progyny did not name the client, but said the client had 670,000 members and represented 13% of Progyny’s revenue in 2023. The company said the client accounted for a “smaller percentage” of its profits.
STAT+ Exclusive Story
Already have an account? Log in
Already have an account? Log in
Monthly
$39
Totals $468 per year
$39/month Get StartedTotals $468 per year
Starter
$20
for 3 months, then $399/year
$20 for 3 months Get StartedThen $399/year
Annual
$399
Save 15%
$399/year Get StartedSave 15%
11+ Users
Custom
Savings start at 25%!
Request A Quote Request A QuoteSavings start at 25%!
2-10 Users
$300
Annually per user
$300/year Get Started$300 Annually per user
View All PlansTo read the rest of this story subscribe to STAT+.
Subscribe Log In fertility, health tech, reproductive health, STAT+ Submit a correction requestReprintsBob Herman
Business of Health Care Reporter
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also the author of the Health Care Inc. newsletter.
Unpacking the business — and secretive inner workings — of the U.S. health care industry